Resilience Expands Clinical and Commercial Drug Product Manufacturing Capabilities and Capacities

National Resilience, Inc. (Resilience), Expands Clinical and Commercial Drug Product Manufacturing Capabilities and CapacitiesNational Resilience, Inc. , a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, today announced the expansion of the company’s clinical and commercial drug product manufacturing capabilities across its network. By scaling this capacity, Resilience aims to provide over 200 […]

Patient-Centred Approach Creating Space In Pharmaceuticals

Apparently, pharmaceutical industry happens to be going through a prominent shift towards patient-centric approaches, thereby recognizing the significance of considering patient perspectives right across drug development as well as the healthcare delivery process. This shift happens to be driven by the desire to elevate treatment outcomes, enhance patient experiences, as well as align healthcare solutions […]

Pharma Companies May Gain From Digital Health Investor Plans

It is worth noting that this year happened to be one of contraction within the digital health space, beginning with a new normal investment climate that involved fewer deals, reduced check sizes, and a smaller group of sector investors, as per Rock Health. Numerous companies within the industry went ahead and filed for bankruptcy, such […]

Pharma Challenge In Singapore – Making The Most of The Flow

It is worth noting that Singapore may still be waiting for its first biotech bellwether, but it has for sure turned a corner in the eyes of many across the West. An advent of investor interest as well as the recent launches when it comes to minded incubators across the country go on to signify […]

10 Vital Strategies For Building Healthcare Infrastructure

It is well to be noted that building sustainable as well as resilient healthcare facilities across Asia happens to be a complex urge that requires a holistic along with an integrated approach. Let us dive into ten crucial strategies that are essential when it comes to creating healthcare infrastructure that goes on to address immediate […]

Etihad Cargo continues strong cool chain product growth trajectory

Etihad Cargo, the cargo and logistics arm of Etihad Airways, achieved year-on-year growth of the carrier’s dedicated cool chain products — PharmaLife and FreshForward — in 2023. The airline recorded the highest volumes of pharmaceuticals transported in Etihad Cargo’s history, achieving a 37 per cent increase in shipments compared to 2022. The carrier also transported […]

WuXi Advanced Therapies Receives FDA Approval to Manufacture Iovance’s AMTAGVI for Advanced Melanoma

WuXi Advanced Therapies , a wholly owned subsidiary of WuXi AppTec announced that the U.S. FDA has approved its Philadelphia site to begin the analytical testing and manufacturing of AMTAGVI for Iovance, which received FDA accelerated approval of its Biologics License Application (BLA) on February 16, 2024. AMTAGVI is a tumor-derived autologous T cell immunotherapy […]

Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing

Charles River Laboratories International, Inc. announced a strategic agreement with Wheeler Bio, Inc., an antibody contract development and manufacturing organization (CDMO) focused on preclinical and early clinical supply of recombinant proteins, providing clients access to Wheeler’s Portable CMC® (Chemistry, Manufacturing and Controls) platform. This new alliance provides early-stage biotechnology companies a unique solution to rapidly […]

Ginkgo, SaponiQx Awarded $31M to Develop Next-Gen Vaccine Adjuvants

The Defense Threat Reduction Agency’s (DTRA) Joint Science and Technology Office (JSTO) for the Chemical and Biological Defense (CBD) Program has awarded, through the Medical CBRN [Chemical, Biological, Radiological, and Nuclear] Defense Consortium (MCDC) requirement 22-05, “Adjuvant Activity to Vaccines Prototype,” a 5-year contract totaling up to $31 million including program options to the team […]

Bachem in conversation with ChromaCon founders

While they were visiting Bachem, we had the chance to sit down and talk with Prof. Massimo Morbidelli, Dr. Lars Aumann, and Dr. Thomas Müller-Späth who together, have brought Continuous Chromatography from an academic idea to a potential new industry standard that Bachem is piloting for use in TIDES. Get an insight into a conversation […]